Top Markets
Coin of the day
Berry Genomics Co.,Ltd Berry Genomics Co.,Ltd

Berry Genomics Co.,Ltd

000710
Rank in Stocks #13831
Berry Genomics Co.,Ltd, a genomics and life science company, develops and... Berry Genomics Co.,Ltd, a genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China. The company offers non-invasive DNA prenatal testing service, genetic disease testing, tumor genetic testing, NextSeq CN500 gene sequencer, and laboratory solutions. It also provides technology services, such as human genome sequencing, transcriptional regulation, single cell/spatial sequencing, animal and plant genome resequencing, genome denovo sequencing, and microbial sequencing, as well as big data services. The company serves various organizations and facilities, including hospitals, research institutions, universities, and enterprises throughout Mainland China, Hong Kong, Macao, Taiwan, Southeast Asia, the Middle East, and Australia. The company was founded in 2010 and is headquartered in Beijing, China.
Share Price
$1.29
Market Cap
$456.97M
Change (1 day)
-1.22%
Change (1 year)
-38.75%
Country
CN
Trade Berry Genomics Co.,Ltd (000710)

Category

P/B ratio for Berry Genomics Co.,Ltd (000710)
P/B ratio as of 2026 TTM: 0
According to Berry Genomics Co.,Ltd latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Berry Genomics Co.,Ltd from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
4.1431 -
US
2.7156 -
US
- -
CN
24.3791 -
US
27.366 -
US